The Journal for Nurse Practitioners
Volume 6, Issue 7 , Pages 551-552 , July 2010

Amylin and Incretin Enhancers for Diabetes Type 2

  • Maren S. Mayhew

      Affiliations

    • Maren Mayhew, MS, ANP, GNP, is the author and editor of Pharmacology for Primary Care Providers, a textbook for NPs published by Mosby.

References 

  1. Kendall DM , Cuddihy RM , Bergenstal RM . Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use . Am J Med . 2009;122:S37–S50
  2. Pratley RE . Overview of glucagon-like peptide-1 analogs and dipeptidyl peptidase-4 inhibitors for type 2 diabetes. Medscape 2008 . Available at www.medscape.com/viewarticle/578051_print Accessed March 7, 2010.
  3. Grossman S . Differentiating incretin therapies based on structure, activity, and metabolism: Focus on liraglutide . Pharmacotherapy . 2009;29(12):25S–32S
  4. Gilbert MP , Pratley RE . Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus . Am J Med . 2009;122:S11–S24

 Suggestions for topics are welcome.

PII: S1555-4155(10)00289-8

doi: 10.1016/j.nurpra.2010.05.008

The Journal for Nurse Practitioners
Volume 6, Issue 7 , Pages 551-552 , July 2010

Article Tools